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Case Presentation
Dr Force: A 35-year-old woman came to an outside hospital 37 weeks’ pregnant
and reporting shortness of breath. A chest radiograph performed in the emergency
department revealed a right pneumothorax. A 12F catheter was placed to drain the
pneumothorax. Subsequently, a persistent air leak developed, and the patient was
transferred to the obstetric service at our hospital. Three days after admission, she
had an uncomplicated vaginal delivery. However, she continued to have a persistent
air leak from her chest tube. Several days later, the air leak ceased but a recurrent
pneumothorax developed. This required the placement of a larger chest tube, which
once again revealed a persistent air leak.
The only significant procedures in the patient’s surgical history were a cesarean
section and a cholecystectomy. She had a 10 pack-year smoking history and no
history of a previous pneumothorax. After the air leak was tracked for 1 week after
delivery, the patient was taken for a video-assisted thoracoscopy. A video-assisted
thoracoscopic resection of a right lower lobe bleb and mechanical pleurodesis were
performed. The patient tolerated the procedure well and was discharged to home on
the fourth postoperative day after her chest tube was removed. The case is being
presented because of interesting findings in the resected specimen.
Dr Patterson: She had had no imaging other than just a chest radiograph?
Dr Force: She had a computed tomographic (CT) scan as well.
Dr Gierada: On the chest radiograph taken when she was transferred here, you
can faintly see the pneumothorax catheter, and there was still a very small right
apical pneumothorax. A follow-up radiograph 3 days later showed almost a com-
plete collapse of her right lung (Figure 1). The following day, the lung had come up
partly in the morning, and a few hours later it was up almost completely. No obvious
lesions were seen in the lungs on images obtained without a pneumothorax present.
A CT scan obtained later that same day showed the pneumothorax, and in the right
lung base there was a cystic lesion with what looked like perhaps some thin
septations with a little thickening of the septations or some vessels running along
them. A very thin-walled inferior portion was adhered to it, so that it looked like a
thin bleb (Figure 2). This is an unusual location for a bleb as a cause of spontaneous
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pneumothorax. Without knowing the pathologic details, the
most likely possibility is that this was a result of an old
infection or perhaps an old congenital lesion like a small
cystic adenomatoid malformation or a sequestration that had
cavitated and formed into a cyst.
Dr Cooper: You put in a chest tube here?
Dr Force: She had a pneumothorax catheter from an
outside emergency department, and we kept that in initially.
That failed, however, so we put in a chest tube.
Dr Cooper: Did the chest tube take care of the problem?
Dr Force: It didn’t, she had a persistent air leak and
never completely resolved her pneumothorax.
Dr Patterson: Was there a big air leak?
Dr Force: There was a persistent leak.
Dr Cooper: Well, what is a persistent leak?
Dr Force: Longer than a week.
Dr Cooper: Couldn’t you put on a Heimlich valve and
send her home?
Dr Force: We could have, but she was young and pretty
anxious to get the tube out. She was reporting a lot of
discomfort with the tube. Furthermore, she is a large
woman, and we were having problems with kinking and
positioning of the tube. I don’t think that she would have
tolerated being sent home with a chest tube.
Dr Horowitz: She had a new baby at home as well.
Dr Force: We should discuss the pathologic data on the
wedge resection of the bulla.
Dr Ritter: There was a lung wedge biopsy sample 4 
1.5 1.0 cm, and on sectioning it showed a bleb. The tumor
had a mixed or mucinous background and was composed of
cells that have abundant eosinocytic cytoplasm, with nuclei
large and condensed (Figure 3). In a higher view we could
see prominent nuclei (Figure 4). Most of these cells were
intermediate trophoblastic cells, and this could be confirmed
with immunohistochemical testing. The tumor was seen
invading blood vessels (Figure 5). Immunostains were per-
formed for human chorionic gonadotropin (HCG), which
was weakly positive (Figure 6), and placental alkaline phos-
phatase, which was strongly positive (Figure 7). On the
basis of the cytohistologic features of the cells and the
immunostaining results, we believe that this represents a
metastatic placental site trophoblastic tumor (PSTT).
Dr Meyers: I think it’s worth mentioning that at the
initial operation we were operating on a persistent pneumo-
thorax. When you resect a bullous lesion or a bleb what you
like to do is have your staple line right in the adjacent
normal tissue. The CT scan showed that there were several
pulmonary artery branches going to the lower lobe that
shared the lateral wall of this bleb. If I had to predict where
the staple line ended up, it would be just right along the
inner face between the abnormal tissue and the normal lung.
We didn’t take a rim of normal lung as you would do if you
knew you were operating on a malignancy. When the pa-
thologists get the specimen, they sacrifice a few millimeters
of tissue. They had no idea that they were looking for any
type of malignancy. It was very uncertain as to what the
margins were, how close the margins were, or whether they
were positive.
Dr Patterson: Could I ask the pathologist to expand on
some remarks about the immunohistochemical testing?
Dr Ritter: The differential diagnosis would include var-
ious types of trophoblastic tumors. Choriocarcinoma, for
example, consists of cells that stain strongly positive for
HCG but weaker for placental alkaline phosphatase. In this
patient’s lesion, the opposite was seen. These tumors are
composed of a mixture of syncytial and cytotrophoblast
Figure 1. Chest radiograph showing collapse of right lung with
pneumothorax catheter in place.
Figure 2. CT scan 4 days after transfer shows pneumothorax and
cystic lesion in right lung base.
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cells. As stated, the cells of this tumor look like this inter-
mediate form of trophoblast, which is different. Choriocar-
cinoma also tends to have more hemorrhage, and you will
see hemorrhagic spaces rimmed by trophoblastic cells.
These tumors appear to be invading the tissue, and they also
tend to invade blood vessels. Once you get HCG positivity
Figure 3. Tumor shows mixed or mucinous background, com-
posed of cells with abundant eosinocytic cytoplasm, and nuclei
that are large and condensed.
Figure 4. Higher-power view than in Figure 4 reveals prominent
nuclei.
Figure 5. Evidence of vascular invasion by the tumor.
Figure 6. Weakly positive immunostaining for HCG.
Figure 7. Strongly positive immunostaining for placental alkaline
phosphatase.
Figure 8. Fluorodeoxyglucose positron emission tomographic
(FDG PET) scan taken January 28, 2002. Nothing is seen in region
of right lower lobe lesion. Some uptake in uterus is as expected
in postpartum patient.
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and you’ve excluded some rare lung cancer that is going to
have HCG-positive cells, you are dealing with some sort of
trophoblastic tumor.
Dr Cooper: At the margin of the wedge resection, did
the lung look normal?
Dr Meyers: Yes. There was no obvious evidence of
malignancy.
Dr Force: PSTTs are included in a spectrum of tumors,
with molar pregnancy on one end and choriocarcinoma on
the other. Women may even embolize normal trophoblastic
cells to the lung during pregnancy. The treatment of tro-
phoblastic tumors centers on chemotherapy, but PSTTs are
fairly resistant to chemotherapy. After discussing the find-
ings with the gynecologic oncologists, it was decided we
should attempt to rule out any possible site of metastatic
disease, given that these tumors tend to metastasize to brain,
bone, lung, kidney. We concluded that in the absence of
other metastatic disease the patient should undergo resec-
tion of any possible site in the pelvis as well as the right
lower lobe, considering the possibilities of a positive true
margin. Before surgery, the patient had a positron emission
tomographic scan performed.
Dr Dehdashti: A fluorodeoxyglucose positron emission
tomographic scan was taken January 28, 2002 (Figure 8)
and was essentially negative. We didn’t see anything in the
region of the right lower lobe lesion. There was some uptake
in the uterus, as would be expected in this postpartum patient.
Dr Force: Subsequently, the patient underwent a right
thoracotomy and right lower lobectomy, as well as a hys-
terectomy and bilateral salpingo-oophorectomy. The lobec-
tomy was a very difficult dissection. The lower lobe was
completely fused to the diaphragm and the chest wall and
was particularly adherent medially adjacent to the phrenic
nerve. This was most likely due to the pleurodesis per-
formed at the first operation.
Dr Meyers: If you look back at her CT scan, she has
these calcified Missouri-style granulomatous lymph nodes
in her hilum. I think that also made the lobectomy dissection
difficult.
Dr Govindan: What did the CT of the abdomen and
pelvis show?
Dr Force: The CT of the chest, abdomen, and pelvis
was significant only for a breast mass that did not light up
on positron emission tomographic scan.
Dr Govindan: Was the breast mass investigated further?
Dr Horowitz: The ultrasonographic appearance of the
breast mass was normal breast tissue. We decided that
aspiration was not required. This is a very interesting case
from our standpoint for two reasons. One, this PSTT is a
very rare tumor. There are only about 100 cases reported in
the literature, so the fact that this one occurred during the
patient’s pregnancy and not postpartum sort of makes it a
little more interesting. The other reason is that a spontane-
ous pneumothorax in a pregnant patient is also a pretty rare
event. Usually spontaneous pneumothoraces in pregnancy
occur in women who have previous lung disease or have
had a previous spontaneous pneumothorax. The PSTT is a
rare variant of gestational trophoblastic disease or gesta-
tional trophoblastic neoplasm, which is a continuum that
includes invasive moles or persistent molar pregnancies to
choriocarcinoma and then this PSTT. Choriocarcinomas
and invasive moles have very elevated -HCG levels, and
that is really how we follow up these patients. This is
contrasted by the PSTT, which is more of a malignancy of
the intermediate cytotrophoblasts that were shown by the
pathologists. Unlike the other two gestational trophoblastic
neoplasms, the PSTT really doesn’t have an elevated HCG
level; you see more elevations in the human placental lac-
togen (HPL), for which this tumor stained very positively.
In this patient the initial postpartum HCG level was 22
IU/mL; for the laboratory here, normal or negative would be
less than 5 IU/mL. The level of 22 IU/mL is slightly
elevated and consistent with her postpartum state, but not as
elevated as we would have expected if this would have been
a choriocarcinoma or an invasive molar pregnancy.
Dr Cooper: Is that a routine postpartum blood test?
Dr Horowitz: I usually don’t check these levels at all. In
fact it was only checked after her pathology came back. We
had also sent out a laboratory test for HPL, and interestingly
that result was negative or in the normal range, so although
her tumor stained positively, her serum level of HPL was
normal. I don’t really know what to make of that, because
we have the diagnosis from the pathologic examination of
the lung resection. As was already mentioned, the treatment
of choice for the PSTT is resection by hysterectomy. Inva-
sive moles and choriocarcinomas, on the other hand, are
exquisitely sensitive to chemotherapy, in particular metho-
trexate or dactinomycin. PSTTs are very chemotherapy
insensitive.
Dr Patterson: You mentioned that some of these neo-
plasms are followed by tracking markers. Is this one of
those tumors?
Dr Horowitz: We could have followed this by tracking
HPL, if it were a marker for her. Unfortunately, HPL was
not elevated in her case. Another marker for PSTTs is
inhibin. I don’t understand why that is a marker for this
particular tumor, but it has been shown to be elevated in
some cases. Unfortunately, in her case inhibin also wasn’t
elevated. She really had no tumor markers with which to
follow up.
Dr Gierada: Is there any chance that the lesion could
have been present from a previous pregnancy?
Dr Horowitz: That’s a very good question. I think it is
possible. Perhaps we could review the pathologic examination.
Dr Ritter: In a section of the uterus there were thick-
walled vessels indicating the previous implantation site.
Clinical-Pathologic Conference Patterson
888 The Journal of Thoracic and Cardiovascular Surgery ● March 2004
CPC
None of the specimens that we received showed tumor. We
did not find any evidence of the tumor in the uterus. This
raises the question about a previous pregnancy. Gestational
trophoblastic disease of all kinds will undergo spontaneous
involution in the uterus. We often do not find tumor in the
uterus, even in patients with metastatic choriocarcinoma. In
the section of the lung we could see several hyalinized
nodules consistent with typical histoplasmosis. We found
nothing residual in the lung itself.
Dr Patterson: Did you section along the staple line? If
there was going to be residual tumor, that’s probably where
you would have found it.
Dr Ritter: Yes we did. There was no evidence of any
residual tumor.
Dr Cooper: What’s the usual presentation for patients
with these tumors?
Dr Horowitz: Most have abnormal bleeding or persis-
tent bleeding postpartum. Most are seen after a normal
pregnancy, as in this case, although you may see symptoms
after a spontaneous miscarriage or after molar pregnancies
as well. Again, most are seen anywhere between 2 weeks up
to 2 years after the antecedent pregnancy, although there are
cases in the literature in which PSTT was found as long as
8 to 10 years after pregnancy.
Dr Cooper: And when the diagnosis is made, what is the
treatment?
Dr Horowitz: In most cases the disease is contained
within the uterus. After diagnosis, you do a metastatic
workup with a chest, abdominal, and usually head CT. If
you don’t see any metastatic disease, then a hysterectomy
would be your treatment of choice and should be adequate
for PSTT. Although PSTT is not a chemotherapy-sensitive
tumor when it is metastatic, as in this case, adjuvant che-
motherapy would be recommended. Multiagent chemother-
apy is used, with etoposide, methotrexate, dactinomycin,
and cyclophosphamide (EMICO). EMICO is standard che-
motherapy both for PSTTs that are metastatic and for other
gestational trophoblastic neoplasms that are widely meta-
static and are in what we consider a high-risk group. High-
risk patients include those who have undergone previous
chemotherapy, have very high HCG levels, or are seen soon
after pregnancy.
Dr Patterson: The presumption is that she had a tumor
in her placenta that metastasized to the lung. There is no
evidence of tumor in her uterus. There isn’t any evidence of
tumor in the resected lung, so why give her all that
chemotherapy?
Dr Horowitz: There is not a lot of experience in the
literature to guide treatment for patients with metastatic
PSTTs. The largest series is about 15 patients from the New
England Trophoblastic Disease Center, and the patients
with metastatic disease who were treated with the combi-
nation of hysterectomy and EMICO did the best. In general,
women who have metastatic PSTT do very poorly. With a
5-year survival of about 40%, we consider it important to be
aggressive, both surgically and with chemotherapy.
Dr Cooper: If in fact aggressive chemotherapy in itself
doesn’t give a favorable prognosis, maybe that’s a good
argument not to do anything, because you know you are
going to knock the hell out of her with that kind of dose and
you don’t know if it’s needed.
If you had a blood sample from before the time of the
pulmonary resection, the initial blebectomy, might you de-
tect the antigen? And if you did and didn’t find it now,
would you then not treat her and just follow her antigen
levels?
Dr Horowitz: We presented this case at our conference
earlier this week, and the consensus was that even though
the uterus and the lung didn’t show persistent residual
tumor, all the participants would be aggressive with che-
motherapy. She is young and will probably tolerate the
chemotherapy regimen therapy well; without it, although
we have limited experience, patients do not tend to do very
well.
Dr Force: Metastatic cancers to the lung presenting as
spontaneous pneumothoraces are rarely seen. Although
cases of spontaneous pneumothorax have been reported
with metastatic choriocarcinoma, there are no reports in the
literature involving metastatic PSTT.1,2 These tumors be-
long to a group of malignancies termed gestational tropho-
blastic neoplasms, a spectrum of tumors that also includes
hydatidiform moles, invasive moles, and choriocarcino-
mas. These malignancies most commonly occur after
molar pregnancies but may arise after any gestational
event. Histologically, PSTTs are primarily composed of
intermediate trophoblasts with extensive vascularization.
They produce HPL and, to a lesser degree, HCG. Most of
these tumors present with vaginal bleeding, and rarely
patients are seen with metastatic disease. Approximately
4% of gestational trophoblastic neoplasms are found to
be metastatic at the time of diagnosis; of these, 80% have
pulmonary involvement. Staging classifications for
PSTTs do not appear to correlate with other gestational
trophoblastic neoplasms, but the presence of metastatic
disease appears to be the most important prognostic in-
dicator.3 PSTT is a rare tumor, and there have not been
any large studies evaluating pulmonary metastasectomy.
Two reports in this Journal have recommended resection
of isolated pulmonary metastases in choriocarcinoma;
however, this tumor behaves differently from PSTT.4,5
Unlike choriocarcinoma, PSTT is not usually sensitive to
chemotherapy, and despite a few reports showing a sig-
nificant response to chemotherapy, treatment of PSTT is
centered around complete resection if possible.6-8
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